Advanced sarcoidosis

People with advanced sarcoidosis include those with chronic disease (active disease for more than 2–5 years) who:

 

Have worsening disease symptoms despite treatment (usually more than 10 mg of corticosteroids and other therapeutic options).

Have continued to need treatment during the past year, whether or not they have had symptoms.

Approximately 5–10% of all diagnosed patients will have advanced sarcoidosis. Although several treatments have been proposed for these people, including recommendations based on the organs involved, the evidence available to help doctors make treatment decisions is limited. Doctors therefore try to balance the need for different therapies at different doses against side effects and the risk of disease progression. In addition to symptoms directly related to inflammation, people with advanced disease often also contend with fatigue, pain, cognitive impairment, small fiber neuropathy, exercise limitation, depression and other comorbidities (such as diabetes and high blood pressure), the latter often linked to side effects of commonly used current treatments.

 

This particular patient population highlights one of the greatest needs in sarcoidosis research: more studies to define effective treatment strategies for people with progressive disease and/or involvement of organs outside the lungs.

 

Source: https://www.stopsarcoidosis.org/what-is-sarcoidosis/

 

Rating: 0 stars, 0 votes.